A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

Clinical trial NCT07365371 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07365371
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Polypoidal Choroidal Vasculopathy (PCV)Neovascular Age Related Macular Degeneration (AMD)

Start date: 2026-01-01
Primary completion: 2027-12-31
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.